tiprankstipranks
Trending News
More News >
Precision BioSciences (DTIL)
NASDAQ:DTIL
US Market

Precision BioSciences (DTIL) Financial Statements

Compare
794 Followers

Precision BioSciences Financial Overview

Precision BioSciences's market cap is currently $97.49M. The company's EPS TTM is $-1.84; its P/E ratio is -0.48; Precision BioSciences is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is $-0.54. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 68.70M$ 48.73M$ 25.10M$ 115.53M$ 24.29M
Gross Profit$ 68.70M$ 48.73M$ 25.10M$ 115.53M$ 24.29M
Operating Income$ -26.16M$ -43.74M$ -62.31M$ -39.38M$ -109.83M
EBITDA$ 13.53M$ -32.04M$ -62.79M$ -20.27M$ -99.19M
Net Income$ 7.17M$ -61.32M$ -111.64M$ -30.60M$ -109.01M
Balance Sheet
Cash & Short-Term Investments$ 86.31M$ 116.68M$ 189.58M$ 143.66M$ 89.80M
Total Assets$ 136.39M$ 159.78M$ 238.17M$ 211.50M$ 150.16M
Total Debt$ 30.05M$ 31.27M$ 24.96M$ 9.11M$ 10.52M
Net Debt$ -55.85M$ -85.41M$ -164.62M$ -134.55M$ -79.28M
Total Liabilities$ 80.00M$ 140.92M$ 177.74M$ 120.33M$ 105.73M
Stockholders' Equity$ 56.39M$ 18.86M$ 60.43M$ 91.17M$ 44.42M
Cash Flow
Free Cash Flow$ -58.70M$ -86.39M$ -49.07M$ -16.66M$ -92.42M
Operating Cash Flow$ -58.45M$ -84.11M$ -45.75M$ -10.85M$ -87.39M
Investing Cash Flow$ -215.00K$ 5.83M$ -3.32M$ -5.80M$ -5.03M
Financing Cash Flow$ 50.45M$ 5.39M$ 94.98M$ 70.52M$ 1.33M
Currency in USD

Precision BioSciences Earnings and Revenue History

Precision BioSciences Debt to Assets

Precision BioSciences Cash Flow

Precision BioSciences Forecast EPS vs Actual EPS